Genome-Wide Association Studies of ARIA From the Aducanumab Phase 3 ENGAGE and EMERGE Studies. Loomis SJ, Miller R, Castrillo-Viguera C, Umans K, et al. Neurology 2024;102:e207919.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Loomis SJ, Miller R, Castrillo-Viguera C, Umans K, et al. Genome-Wide Association Studies of ARIA From the Aducanumab Phase 3 ENGAGE and EMERGE Studies. Neurology 2024;102:e207919.
PMID: 38165296